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This paper investigates the extent to which conclusions from international comparison of 
health spending depend on different adjustment methods. The analysis shows, first, that health 
spending figures differ significantly because of different accounting standards. More 
specifically, spending on long term nursing care is not  treated the same way in all the 
countries. Next, the rankings differ depending on whether spending is adjusted for purchasing 
power parity and health specific purchasing power adjustment. Finally, the paper examines 
the problem of how to quantify the degree to which an adjustment method changes the 
outcome of a comparison. A rank based approach sum changes in rank and compare this to 
maximum rank change possible. A share based approach sum changes in each units share of 
the total. Both approaches create a measure that is bounded between zero and one, but the 






Countries are often ranked based on health spending per capita. The ranking is sometimes used to 
argue in favor of more health spending  if the country is low on the list  or as an indicator of 
inefficiency when a country is ranked high in spending but low on indicators of health. For instance, 
Jacobs and Skocpol (2010) use the OECD figures to argue that "other nations get hugely more bang 
for the bucks than the United States Does."  Similarly Cutler and Ly (2011) argue that the gap 
between spending and outcome in the US compared to other countries "raises the possibility of 
substantial waste." The  OECD  spending figures are also used in regressions that explore the 
relationship between spending and health status across time and countries (See Nixon and Ulmann, 
2006, for a review of 38 papers using spending as an independent variable). All this makes the 
reliability of health spending figures important. If it turns out that the comparison differ because of 
accounting standards and adjustment methods, then we should be cautious when trying to draw 
analytical or policy implications from the rankings. 
This article will investigate the extent to which spending and rankings vary depending on different 
adjustment methods based on information from the OECD Health Data. The analysis shows, first,  
that health spending figures differ  significantly  because  of  different accounting standards. More 
specifically, long term nursing care spending is not treated the same way in all the countries. Some 
countries classify it as a health expense, others classify it as social spending.  Next, the rankings differ 
depending on whether spending is adjusted for purchasing power parity or not. This is to be 
expected. There is a reason one uses PPP adjustment – to adjust for price differences - and this 
reason implies that there should be some change after applying the adjustment. The true problem is 
that general PPP adjustment is misleading because the conclusions change if we use health specific 
purchasing power adjustment instead of using the general consumer price index. Finally, the paper 
examines the problem of how to quantify the degree to which an adjustment method changes the 
outcome of a comparison. 
 
2. Validity: Are the numbers comparable?  
The OECD data on health spending is based on the system of health accounts (SHA).  Total spending 
on health is defined as the sum of all private and public expenditure and investments in a set of sub-
categories. One of these sub-categories is spending on long term nursing care (LTNC). This is an 
important category and for some countries it constitutes about 25% of all health care spending. 
However, as shown in Table 1, the reported numbers differ greatly between countries. Some report 
very little  spending on long term nursing care. Even countries that are geographically and 
institutionally similar, such as the Nordic countries, report very different numbers. This raises the 
suspicion that a major component of total spending is mismeasured.
1
                                                           
1 This section is inspired by a paper presented by Jes Søgaard at the Nordic Health Economics Study Group 
(NHESG) in 2009. He pointed out the problem and has provided a detailed analysis (unpublished manuscript). 
  To what extent this is a 
problem depends on whether the missing spending is simply classified in another sub-category that is 
included in the total, or whether it is excluded from health spending overall. If countries just differ in 
terms of which sub-category  they use to report their expenses, the total will still be comparable. 3 
 
Data and documentation from the OECD itself indicate that the problem is not just differences in sub-
classification among health expenses. The guidelines for how to treat spending on long term nursing 
care is vague about whether long term care is a social expense or a health expense. This vagueness 
has led to different practices in different countries. As shown in Table 1, countries which report little 
spending on long term nursing care, tend to report more spending on long term social care (LTSC). 
Since spending on long term social care by definition is not health spending, this difference implies 
that the figures for total health spending  are misleading because of differences in accounting 
standards.  
To quantify the importance of the problem, consider the extent to which the Norwegian health 
spending is above the Nordic average. If one uses the OECD numbers for total health spending (PPP 
adjusted, 2007), Norway appears to spend 47% more than the other Nordic countries.  This is 
misleading because the Norwegian figures include spending on long term nursing care which other 
countries categorize as long term social care. To account for this one can either exclude reported 
LTNC from all countries or one can include both LTNC and LTSC in the total health spending figures 
for all countries. In both cases the difference between Norway and the other countries drop from 
47% to about 30%. This implies that different accounting standards account for more than one third 
of the observed difference in spending.  
 
Table 1 Health spending in the Nordic countries, 2007 







               
Total health expenditure  4 763  3 323  3 512  2 840  3 319  3 249  47 % 
               
                Long term nursing care 
(LTNC)  1 177  255  718  325  640  485  143 % 
Long term social care  0  1 023  0  387  0  353 
  (LTSC) 
 
              Total health expenditure 
              ... when LTNC is excluded  3 586  3 068  2 794  2 515  2 679  2 764  30 % 
... including LTNC and LTSC  4 763  4 346  3 512  3 227  3 319  3601  32 % 
Source: OECD Health Data, 2007, PPP adjusted dollars 
 




3. How much does different conversion methods affect the cost comparison? 
Even if we ignore measurement problems, cost comparison can be misleading because of 
biases in the methods used to compare the costs. This section deals with this problem. 
To compare costs it is necessary to convert expenditures to a single unit of measurement. It 
is possible to use natural units such as “work hours” and “number and amount of 
pharmaceuticals”, but it will result in a multi-dimensional measure. If one wants to avoid 
this, there are several options (see Gerdtham and Jönsson 2000 more more on this). First, 
expenditures measured in national currencies can be converted to a common unit, such as 
Euro or USD, using annual exchange rates. The strength of this procedure is its simplicity, the 
weaknesses include the fact that the exchange rate does not consider price and cost-
differences between countries and that the exchange rate may fluctuate too much in the 
short run to be a useful unit of conversion. Converting the expenditure using purchasing 
power parity rates adjusts for this by using the price of a standardized basket of goods and 
services when converting health spending from national currency units. This takes prices into 
account, but it also includes prices of goods unrelated to the health sector. A health specific 
purchasing power parity index would be preferable, but this is not widely available since 
there is no agreement on standardized basked of health goods and prices are not easily 
available. When using health specific PPP one should also distinguish between methods that 
adjust for the price of input factors and methods that are based on the price of outputs. For 
instance, adjusting health expenditures based on differences in the wage levels of health 
workers in different countries is an example of adjusting for the price of inputs. Adjusting for 
the total price of outputs, such as a hip-replacement, may give a different result. Altogether 
this means that there are at least four important and different methods to adjust costs 
before comparing health spending across countries: 
1.  Exchange rates 
2.  Purchasing Power Parity 
3.  Input based health specific purchasing power parity 
4.  Output based health specific purchasing power parity 
The question is to what extent the measured spending will differ depending on which of 
these four measures that is used. Moreover, if the results differ one must ask which method 
that produce the most useful results. This may differ depending on the type of questions one 
is interested in, so the conclusion need not be that one conversion method is best.  
Figure 1 show the size of the differences in health spending in the OECD countries (relative 
to US spending) depending on whether spending is measured in exchange rate dollars or 
purchasing power parity dollars. For some countries the difference is dramatic. For instance, 
the Norwegian spending figures are slightly higher than the US if measured in terms of 
dollars based on the exchange rate. However, because Norway is an expensive country, if we 5 
 
use the official PPP adjusted scale Norwegian health spending is only two thirds of the US 
health spending. In this case the choice of adjustment method is clearly important and not 
just a minor detail that does not affect the main outcome of the comparison. 
 
   6 
 
Figure 1 Health spending in OECD countries measured as a proportion of US health spending 

























































































































































































































































Exchange rate dollars  PPP-dollars 7 
 
Table 2 Differences in health spending relative to US spending depending on whether the 
spending is measured in dollars using the exchange rate dollars or purchasing power parity 
dollars 
Country 
Difference from US if 
measured using the 
exchange rate 
 
Difference from US if 
measured in PPP-dollars 
Absolute 
difference 
Norway  101 %  66 %  35.2 % 
Denmark  76 %  49 %  27.6 % 
Switzerland  84 %  61 %  22.3 % 
Sweden  62 %  46 %  15.9 % 
Ireland  62 %  46 %  15.9 % 
United Kingdom  54 %  41 %  12.8 % 
Finland  52 %  40 %  12.6 % 
France  62 %  49 %  12.5 % 
Austria  63 %  52 %  11.1 % 
Australia  55 %  46 %  8.5 % 
Germany  58 %  50 %  8.2 % 
Canada  60 %  53 %  6.9 % 
Slovak Republic  15 %  22 %  6.8 % 
Czech Republic  16 %  22 %  6.6 % 
Italy  43 %  37 %  5.6 % 
Hungary  14 %  19 %  5.1 % 
Poland  10 %  14 %  4.6 % 
New Zealand  38 %  34 %  4.5 % 
Korea  19 %  23 %  4.3 % 
Chile  8 %  12 %  3.4 % 
Estonia  12 %  15 %  3.4 % 
Slovenia  25 %  29 %  3.3 % 
Turkey  7 %  11 %  3.3 % 
Spain  37 %  36 %  0.8 % 
Japan  38 %  37 %  0.7 % 
Greece  37 %  37 %  0.1 % 
United States  100 %  100 %  0.0 % 
 8 
 
The aim of using PPP dollars as opposed to exchange rate dollars, is to adjust for differences 
in price  (including the price of labor). If the aim is to compare spending in different 
countries, the relevant price is not the general price level, but the price of health services. 
This is an important point because some countries, like the US, have relatively high health 
costs, but low costs for many other goods and services. In this case, using the general price 
level, as opposed to the health specific price level,  when converting to PPP dollars will lead 
to inflated numbers.  
To quantify the importance of the conversion methods, it is necessary to have an index of 
health prices.  There is no such index available on an annual basis from the OECD, but there 
are some data and previous calculations that can be used. As a first attempt one might use 
data on wages since wages represent a large share of health expenses. The OECD Health 
Data contains information about remuneration for nurses and physicians. The information is 
incomplete and of questionable quality, but it is used here as a starting point to capture 
differences in input costs. 
Information about output prices is even more sparse, and of even worse quality. Once again, 
as a starting point, it is possible to use some of the results from the HealthBasket project in 
which expert respondents in nine different countries were asked to calculate typical total 
costs of treatments based on a brief description of a patient (Busse et al. 2008).
2
Using nurse wages as a proxy for input prices and the cost of treating hip fractures as a proxy 
for output price, Table 3 shows the potential importance of using health specific PPP dollars. 
Unfortunately, the OECD data on remuneration is very incomplete so the final results are 
only available for some countries. Once again the conclusion is that the choice of adjustment 
method matters a great deal. For instance, depending on which measure one chooses, US 
health spending is 1% less than Norway or 60% higher than higher than in Norway (se Figure 
2). To some extent the large difference can be blamed on the incomplete data behind the 
health PPP, but even in the OECD data one finds differences that are too large to be credible. 
Even the OECD itself, who has calculated health specific PPP using a wider basis, produced 
numbers with a "huge difference" depending on whether one used health specific PPP or 
standard PPP  (Castles, 1997). For this reason they continued to rely on standard PPP 
adjustment, despite its misleading conclusions. For instance, the US has higher health prices 
than many other countries, but lower prices on other goods and services. In this case, using 
general PPP inflate the reported US health spending (See Frech 2009 for more on this). 
 The project 
calculated costs for ten diagnoses, and as a starting point the cost of treating a hip fracture 
has been used as a proxy of health care prices at the output level (Stargardt 2008). Hip costs 
were used because information about the cost of treating hip fractures was also available 
from other countries outside the HealthBasket project. 
                                                           
2 The project and its results is documented in three special issues: Special issue of European Journal of Health 
Economics, volume 6, November 2005. Special issue of Health Care Management Science, 9(3), 2006 and most 
importantly (reporting the results):  Special issue of Health Economics 17(S1), 2008. 9 
 
 
Table 3 Differences between health spending using all four conversion methods 








Norway  7 354  4 791  6 657  12 669 
United States  7 285  7 285  7 285     7 285  
Australia  3 975  3 353  4 015     6 824 
United Kingdom  3 925  2 990  3 977  14 033 
New Zealand  2 798  2 471  3 740     6 078 
Source: Calculations based on OECD Health Data, remuneration for nurses and HealthBasket 
project (Hip treatment costs). 
 
 
Figure 2: Differences between the Norwegian health expenditures and other countries using 
different adjustment methods 
 
 
4. A possible counterargument - and how it could be answered 
The conclusion that using health PPP instead of standard PPP produce very different results 
depends on the choice of which country to use a benchmark. In Figure 2, the differences are 
calculated using Norway as a benchmark (i.e.  the spending of the other countries is 
measured in terms of deviations from the Norwegian spending). Using a different country as 
benchmark would produce different results. Moreover, if the benchmark country is more 
sensitive to changes in adjustment method, then we may get the impression that the 























problem applies to all comparisons based on deviations from a benchmark. For instance, the 
deviation calculated in Table 2 use US spending as a benchmark and using another country 
as benchmark would produce different results. 
To answer the charge that the results depend on the choice of benchmark, it is possible to 
try out other benchmarks and see if the results differ. An alternative approach would be to 
develop an index that does not depend on a benchmark. One could, for instance, run the 
comparison many times using each country as a benchmark and take the overall average as a 
measure of the degree to which the two methods produced different results. Formally, to 
compare the difference (∆) between two adjustment methods, a and b, on a variable y for n 
units (i=1..n), the average in Table 2 correspond to calculating the following using a fixed unit 






















Although this takes care of the problem of using a benchmark that is misleading, there is a 
possible problem: There is no upper boundary. This may make it difficult to know whether 
the end result is small or large.
3
 
  To solve this one could use ordinal rankings. Let r symbolize 
the ranking of a unit among n units. We can then take the difference between the ranking of 
each unit under condition a  and  b, and sum the absolute  rank differences to get an 








This will have an upper boundary since a ranking has a natural maximum - no unit can be 
ranked higher than 1 or lower than n. It is then possible to divide the sum by the maximum 
possible instability to get a measure where 0 would be no change and 1 would be maximum 
                                                           
3 The lack of a precise upper boundary need not create a problem. There is no logical upper boundary on a 
salary and we still know when a salary is high. But in this case it is based on our experience of what a high 




No single value can be larger than the sum of all values, so this has an upper bound. 
 This might be useful sometimes, but often the cardinal information is desired. In 
the case of health expenditures, the degree to which US spending is higher than the other 
countries is used as an argument, not only the fact that it has the highest expenditure. Given 
that there is no upper logical boundary to health spending, it may - at first sight - seem 
difficult to create an index that respects the cardinality of the data at the same time that it 
produces a bounded number. However, it is possible to produce a bounded number even if 





Now, for two different adjustment methods, a and b, we can calculate the difference in the 





This will have an upper bound since each observation has a maximum (See appendix 2). 
Unlike the measure based on rankings, this measure is also sensitive to cardinal changes that 
do not affect rankings. 
Calculating the numbers based on the OECD data, produce the following results. When using 
the US as a benchmark country, and comparing health spending using exchange rates vs. PPP 
dollars, the average difference in between the two methods was 9.9% Conceptually, this is 
the average of the absolute differences in Table 2. The ranking difference sums to 47 for 31 
observations (average 1.5). Many of the ranking differences are zero, but a few are large. 
Finally, taking the differences between the shares of the total when spending is measured 
using exchange rates vs. PPP dollars, gives a sum of 0.17 and an average percentage change 
(in the share a country represents, depending on whether one measures spending in 
exchange rate dollars of PPP dollars) of 8.8. More work remains to be done to understand 
the properties of the various measures, and one should be careful not to focus too much on 
averages since it may hide large changes among some important units. 
 
5. What should be done? 
The fact that international comparisons  of health spending is sensitive to accounting 
differences and adjustment methods is not new. This paper has contributed with some new 
examples of how large the problem is, but the underlying issues have been known for a long 
                                                           
4 Interestingly, maximum instability could be achieved when rankings are random i.e. previous ranking gives no 
information of value for the next ranking, but maximum instability might also be defined by a complete and 
deterministic reorganization (the last becomes the first and so on).  See appendix 1 for more. 12 
 
time. For instance, Gerdtham and Jönsson described  many of the same problems and 
conducted similar calculations more than 20 years ago. Despite several on- (and long-) going 
projects  by the OECD and the WHO, the problem remains. This raises the question of 
whether the empirical and conceptual problems are too large to conduct useful international 
comparisons of health expenditure. The usefulness of a specific adjustment and comparison 
depends on the aim. If the aim is simply to say something about the volume of health 
services, then it may be better to stick to natural units in a multidimensional measure. It 
seems cumbersome and, given the limitations in data and method, unreliable to measure 
volume in money and then to adjust it for differences in prices in order to get back to a 
volume measure. Advances in data collection and method may make it more reliable and in 
some cases perfect precision is not needed to draw conclusions.
5
   
 At the very least one 
should be aware of the problems. Knowing that the comparison can give almost any result 
depending on the methods used, is important knowledge in itself since it may vaccinate 
against unguarded policy conclusions based on an isolated and misleading  comparison. 
                                                           
5 For instance at a WHO conference (Tandon et al. 2002) it has beensuggested that a latent variable approach 
in which multi-dimensional incomplete health price data can be used to estimate a latent unobserved variable 
(the general health price level). Although interesting, it seems to assume that the different dimensions of 
health price are correlated i.e. that high pharmaceutical prices go together with high salaries to nurses. 13 
 
Appendix 1: The formula for maximum rank difference 
The formulas for the maximum possible rank difference sum depends on whether the number of 
elements (n) is even or odd. For even n, two different rankings produce a symmetric series of 
absolute differences. For instance, n = 6, gives the following series of absolute differences when the 
ranking is reversed: 5, 3, 2, 1, 1, 3, 5 (See illustration below). Ths sum of this series is not immediately 
obvious, but remembering the probably false story about Gauss’ trick for summing the numbers from 
1 to 100, we can use a similar trick here. By adding the elements in the lower half to the elements in 
the upper half, we get a new list of constants: n + n + n. There are n/2 elements on this list, so the 
sum of all the elements is given by: 
 





For odd numbers, things are slightly more complicated because the number of elements on the new 
list cannot be half that of the original. Instead we have a (n-1)/2 elements each with a value of n+1. 
The formula for the maximum possible rank difference is then: 
 
 
𝑀𝑎𝑥 𝑟𝑎𝑛𝑘 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑠𝑢𝑚(𝑜𝑑𝑑 𝑛) = 
1
2
(𝑛 + 1)(𝑛 − 1) 
 
 
The logic behind the formulas is illustrated in the following table: 
 
Rank A  Rank B  Absolute Difference  Symmetric  Sum 
1  6  5  1  6 
2  5  3  3  6 
3  4  1  5  6 
4  3  1 
    5  2  3 
    6  1  5 
   
          Rank A  Rank B  Absolute Difference  Symmetric  Sum 
1  7  6  2  8 
2  6  4  4  8 
3  5  2  6  8 
4  4  0 
    5  3  2 
    6  2  4 
    7  1  6 
       14 
 
Appendix 2: Maximum share difference 
For two units, the maximum possible difference is that the first measure or method tells you that 
unit one makes up the whole of the total while the the other unit makes up all of the total on the 
other approach. The maximum possible difference is then two. The same result can be generalized. 
We can go from one unit having everything to another unit having everything in which the absolute 
difference in shares is 2.  
 
Another approach is to compare an equal distribution with the most unequal distribution possible. 
Imagine that on one approach all units come out as having an equal share of the total (1/n). 
Compare this with another approach which indicates that the distribution in most unequal i.e. one 
unit has everything and all the other units nothing. We then have: 
Approach A (equality)  1/n  1/n  …  1/n  1/n 
Approach B (max inequality)  0  0 
 
0  1 
Absolute difference |A-B|  1/n  1/n  …  1/n  1 - 1/n 
 




















As n approaches infinity, the sum becomes 2, so for large samples, the maximum possible sum of 
absolute differences in shares is two. For small samples it is still possible to have a difference of two, 
but in this case it is achieved by going from one having everything to another having everything i.e. 
the initial distribution is also unequal. 
 
In any case, this establishes an upper bound and enables us to create a standardized measure, 
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